Biologics : targets & therapy

BACKGROUND: Endometriosis (EMs), which causes significant pain and infertility, continues to affect women of reproductive age, yet its molecular mechanisms remain inadequately defined. N6-methyladenosine (m6A) modification is the most preva…

BACKGROUND: Global pandemic identified as coronavirus disease 2019 (COVID-19) has resulted in a variety of clinical symptoms, from asymptomatic carriers to those with severe acute respiratory distress syndrome (SARS) and moderate upper resp…

On August 24, 1998, Remicade® (infliximab), the first tumor necrosis factor-α (TNF) inhibitor, received its initial marketing approval from the US Food and Drug Administration for the treatment of Crohn's disease. Subsequently, Remicade was…